Press "Enter" to skip to content

EU Approves Olaparib as Frontline Maintenance for BRCA+ Ovarian Cancer – Targeted Oncology

admin 0

EU Approves Olaparib as Frontline Maintenance for BRCA+ Ovarian Cancer  Targeted Oncology

Olaparib has been approved by the European Commission as a treatment in the maintenance setting for adult patients with advanced BRCA1/2-mutated …

“ovarian cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *